K
Kate Bramham
Researcher at King's College London
Publications - 130
Citations - 3431
Kate Bramham is an academic researcher from King's College London. The author has contributed to research in topics: Pregnancy & Kidney disease. The author has an hindex of 26, co-authored 93 publications receiving 2536 citations. Previous affiliations of Kate Bramham include John Radcliffe Hospital & St Thomas' Hospital.
Papers
More filters
Journal ArticleDOI
Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis.
TL;DR: This systematic review, reporting meta-analysed data from studies of pregnant women with chronic hypertension, shows that adverse outcomes of pregnancy are common and emphasises a need for heightened antenatal surveillance.
Journal ArticleDOI
Bacteraemia complicating severe malaria in children
TL;DR: It is concluded that invasive bacterial disease may contribute to the pathophysiology of the clinical syndrome of severe malaria in an important subgroup of children and that young children with severe malaria be treated with broad-spectrum antibiotics in addition to antimalarial drugs.
Journal ArticleDOI
Pregnancy in Renal Transplant Recipients: A UK National Cohort Study
Kate Bramham,Catherine Nelson-Piercy,Catherine Nelson-Piercy,Haiyan Gao,Matthias Pierce,Naomi Bush,Patsy Spark,Peter Brocklehurst,Peter Brocklehurst,Jennifer J Kurinczuk,Marian Knight +10 more
TL;DR: Most pregnancies in the United Kingdom in women with kidney transplants are successful but rates of maternal and neonatal complications remain high.
Journal ArticleDOI
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
Kate Bramham,B J Hunt,S Germain,I Calatayud,Munther A. Khamashta,Susan Bewley,Catherine Nelson-Piercy +6 more
TL;DR: Women with thrombotic APS (Group 3) have higher rates of pregnancy complications than those with obstetric APS and treatment with aspirin and LMWH is associated with improved outcomes for women with previous late fetal loss or early delivery due to placental dysfunction.
Journal ArticleDOI
First-trimester low-dose prednisolone in refractory antiphospholipid antibody–related pregnancy loss
TL;DR: The addition of first-trimester low-dose prednisolone to conventional treatment is worthy of further assessment in the management of refractory antiphospholipid antibody-related pregnancy loss, although complications remain elevated.